Batch Ventures invests in Autoheal AI Inc.
Funding Provisional 90% confidence first seen
Autoheal AI Inc. raised a $7.9M seed funding round to build a unified platform for evaluating and “healing” fleets of AI agents used in software factory development workflows. The round was led by Innovation Endeavors and included participation from Batch Ventures, alongside other investors. This matters because it funds enterprise-focused infrastructure for shared evaluation, security controls, and automated pull-request-based fixes for underperforming AI agents.
The deal
Autoheal AI Inc $7.9M Seed · announced 28 Sep 2026
Investors Darkmode Ventures Batch Ventures
Deal terms as reported in the coverage below.
Decision brief
- What changed
- Autoheal AI Inc. raised a $7.9 million seed round to build a platform for evaluating and "healing" fleets of AI agents used in software-development workflows. The round was led by Innovation Endeavors and included Batch Ventures and other investors.
- Why it matters
- This funding supports a new layer of enterprise AI infrastructure aimed at operational control over multiple coding agents, including shared evaluation, security controls, and automated pull-request-based fixes under human approval. For leaders deploying AI in software delivery, the event matters because it signals growing vendor focus on governance and remediation tooling for agent fleets, not just agent creation. The practical decision relevance is whether to track or test platforms that promise safer, more measurable agent operations in private-cloud or enterprise-controlled environments.
- Evidence
- The provided coverage comes from a single SiliconANGLE article reporting that Autoheal raised $7.9 million to build a unified platform for evaluating and fixing AI agents in software factory workflows. It specifically says the company plans shared context, evaluation, a "healer" agent that opens Git-verified pull requests under human approval, and enterprise-specific small language models in customers' private clouds.
- What remains uncertain
- The coverage is based on one report and largely on company-stated plans, so product maturity, customer adoption, and implementation results are not independently verified. It is also unclear how differentiated Autoheal's approach is versus internal tooling or competing agent-management platforms, and whether Batch Ventures' participation implies any broader commercial partnership.
- Monitor next
- Watch for Autoheal's first announced enterprise deployments or product releases showing measurable outcomes for agent evaluation, security controls, and pull-request-based remediation.
Analytical support, not advice — assumptions and open questions stated above.